TSX:OGIPharmaceuticals
Why Organigram (TSX:OGI) Is Up 27.1% After Strong FY2025 Results And Bullish 2026 Revenue Guidance
Organigram Global Inc. has reported its fiscal 2025 results, with sales rising to C$403.02 million and revenue to C$259.18 million, while net loss and loss per share from continuing operations narrowed year on year.
Alongside record market share in Canadian recreational cannabis and growing international sales, the company has guided for Fiscal 2026 net revenue above C$300 million, supported by new product launches, acquisitions, and cultivation and extraction advances.
With strong full-year...